Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest Peptides Stories

Why Some Wound Infections Become Chronic Explained By Researchers
2013-12-18 12:50:39

University of California - Riverside UC Riverside's Manuela Martins-Green shows how decreasing levels of 'reactive oxygen species' can break cycle of unhealing wounds Chronic wounds affect an estimated 6.5 million Americans at an annual cost of about $25 billion. Further, foot blisters and other diabetic ulcers or sores account for the vast majority of foot and leg amputations in the United States today. Why does treating chronic wounds cost so much? What complicates chronic wound...

2013-12-16 08:25:09

DUBLIN, Dec. 16, 2013 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/k8hhr8/peptide) has announced the addition of the "Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Peptide therapeutics is currently offering a new commercial potential to pharmaceuticals and biotechnology industry. To exploit this emerging market,...

2013-11-08 12:23:40

DUBLIN, November 8, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/tfh2m9/aptamers_market) has announced the addition of the "Global Aptamers Market Technology Trend Analysis Market Report 2013-2018" [http://www.researchandmarkets.com/research/tfh2m9/aptamers_market ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The global aptamers market is valued at $287 million in 2013 and is...

2013-10-30 23:26:16

Xtalks presents an exciting live webinar on Thursday, November 7, 2013 at 2:00pm EST (11:00am PST) on RNA Aptamers. Toronto, Canada (PRWEB) October 30, 2013 RNA aptamers are an emerging class of molecules demonstrating significant potential in the diagnosis and treatment of human diseases. RNA aptamers are small, single-stranded RNA molecules that are functionally analogous to antibodies. However, RNA aptamers can be produced by chemical synthesis and their small size, low immunogenicity,...

2013-10-30 15:40:18

Berkeley Lab researchers take cues from nature in designing a programmable nanomaterial for biosensing Taking inspiration from the human immune system, researchers at the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) have created a new material that can be programmed to identify an endless variety of molecules. The new material resembles tiny sheets of Velcro, each just one-hundred nanometers across. But instead of securing your sneakers, this molecular...

2013-10-29 23:27:33

Aptamers Market report categorizes the global market into geography, applications, and aptamer type. http://www.marketsandmarkets.com/Market-Reports/aptamers-technology-market-1167.html (PRWEB) October 29, 2013 The "Aptamers Market - Technology Trend Analysis By Applications - Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis - Global Forecasts to 2018 " analyzes and studies the major market drivers,...

2013-10-29 12:22:18

SAN DIEGO, Oct. 28, 2013 /PRNewswire/ -- CA BOTANA International announces several novel peptides designed to improve the skin's ability to defy aging, and provide a more youthful, vibrant appearance to the skin. These peptides were generated from the research collaboration between CA BOTANA International, Molecular Botanicals LLC and StemNext LLC and intended as raw materials for cosmetic formulations. (Logo: http://photos.prnewswire.com/prnh/20130517/AQ16286LOGO) Bioactive peptides of high...

2013-09-18 12:31:10

GARCHING, Germany, September 18, 2013 /PRNewswire/ -- - In-licensing of superior DOTA-Tyr3-octreotide - Pharmaceutical developmentfor treatment of NETs - Excellent pharmacokinetic properties ITM Isotope Technologies Munich AG (ITM) today announced that it has entered into an exclusive licensing agreement with Progenics Pharmaceuticals Inc. for pharmaceutical development and commercialization of radiolabeled DOTA-conjugated somatostatin...

2013-09-17 08:30:47

"REGULATE-PCI" to Study REG1 in Patients Undergoing Percutaneous Coronary Intervention BASKING RIDGE, N.J., Sept. 17, 2013 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the discovery and development of novel, first-in-class, actively controllable antithrombotic drug systems for acute and sub-acute cardiovascular indications, today announced the enrollment of the first patient in its REGULATE-PCI clinical trial. REGULATE-PCI is a...

2013-08-26 23:23:58

American Peptide Company (APC) announces the expansion of their large scale cGMP peptide synthesis capabilities with the addition of a 300 Liter solid phase synthesis reactor and a 294 Liter tray lyophilizer. Sunnyvale, CA (PRWEB) August 26, 2013 American Peptide Company (APC) announces the expansion of their large scale cGMP peptide synthesis capabilities with the addition of a 300 Liter solid phase synthesis reactor and a 294 Liter tray lyophilizer. American Peptide’s state of the art...